Results

Total Results: 559 records

Showing results for "resistance".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
    April 11, 2018 - antibiotics, where safely possible, to reduce potential harms including development of antibiotic resistance
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - from BPH due to BOO or changes in smooth muscle tone: “BOO and/or changes in smooth muscle tone and resistance
  3. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - Layout 1 Background Type 2 diabetes is characterized by insulin resistance accompanied by progressive
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
    October 05, 2012 - recognized, the present evidence does not report on important outcomes such as ABT adverse outcomes, resistance
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-disposition-comments.pdf
    January 02, 2024 - Disposition of Comments_Comparative Effectiveness Review No. 269_Respectful Maternity Care: Dissemination and Implementation of Perinatal Safety Culture To Improve Equitable Maternal Healthcare Delivery and Outcomes Comparative Effectiveness Review Disposition of Comments Report Title: Respectful M…
  6. effectivehealthcare-admin.ahrq.gov/products/binge-eating/research-protocol
    December 01, 2019 - weight status or stabilization Hypertension Type 2 diabetes, impaired glucose tolerance, insulin resistance
  7. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
    January 01, 2007 - Layout 1 Background Depressive disorders such as major depressive disorder (MDD), dysthymia, and subsyndromal depression (including minor depression) may be serious disabling illnesses. MDD is the most prevalent, affecting more than 16 percent (lifetime) of U.S. adults. In 2000, the U.S. economic burden of depressiv…
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - Ann Intern Med 19757866 Head lice treatments and school policies in the US in an era of emerging resistance
  9. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - PEPTIC ULCER #11 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 11: Peptic Ulcer Disease and Dyspepsia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 ww…
  10. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/14_substance_abuse_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.…
  11. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - PEPTIC ULCER #11 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 11: Peptic Ulcer Disease and Dyspepsia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 ww…
  12. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahr…
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
    April 01, 2013 - may have the unanticipated downside of actually compromising the balance between tumor and patient resistance
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-children_executive.pdf
    December 01, 2016 - practitioner ehausition, patient dissatisfaction with care Practitioner: burnout, turnover, and resistance … to strategy Organization: cost, failure to sustain EBP, resistance to change Modifiers of Effectiveness
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - Metabolic effects: metabolic syndrome, change in body composition, fasting glucose, insulin sensitivity/ resistance … studies; nevertheless, issues impacting longterm treatment success, such as treatment compliance and resistance
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance … glycemic control instructed to take metformin for 6-10 months 12 months Glycemic control, insulin resistance
  17. effectivehealthcare-admin.ahrq.gov/products/arthritis-knee-physical-therapy/research-protocol
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_executive.pdf
    August 01, 2012 - anecdotal evidence from providers noted that new bundled payment systems faced significant initial resistance
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
    August 12, 2016 - attention given to additional biomarkers addressed in RCTs, such as effects on glycemia, insulin resistance
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-206-evidence-summary-sodium-potassium.pdf
    June 01, 2018 - intake that had shown an association in some studies with adverse effects on blood lipids and insulin resistance

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: